sciencebriefs
10:16in productionCh. 1 · San Juan, 2011/ 10:16 · ceiling 15 min
Genetics · Medicine

Jennifer Doudna

Jennifer Doudna and Emmanuelle Charpentier

They didn’t invent gene editing — they made it programmable, predictable, and portable.

Doudna and Charpentier’s 2012 work established CRISPR-Cas9 as the first programmable, RNA-guided DNA cleavage system. It relies on Cas9 protein and a synthetic guide RNA chimera. It works in vitro. It does not demonstrate editing in living organisms or repair outcomes. It is the origin of all subsequent CRISPR applications — not a refinement, but the first functional design.

GeneticsMedicineGeneticsScientific methodMortalityGenetics across the network →
Chapters & takeaways4
  1. 1:07
    San Juan, 2011

    The collaboration began in 2011 in San Juan — not in a lab, but at a conference.

  2. 2:37
    The tracrRNA breakthrough

    tracrRNA isn’t just part of the system — it’s essential for crRNA maturation, and its fusion with crRNA creates the functional guide.

  3. 4:35
    One enzyme, one RNA, one cut

    Cas9 cuts DNA like scissors — but only where the guide RNA tells it to, and only when that RNA is a chimera of crRNA and tracrRNA.

  4. 6:20
    From bacterial immunity to lab tool

    The system evolved to slice viral DNA — and was repurposed using easily created synthetic RNA.

Worth your time?

Yes. Study the whole thing.

4.5/ 5
What works
  • programmable DNA cleavage
  • guide RNA design
  • Cas9–RNA complex formation
  • in vitro DNA targeting
What does not
  • editing in eukaryotes
  • in vivo delivery
  • repair pathway control
  • off-target quantification
Study it if
  • biologists
  • geneticists
  • bioethicists
Skip it if
  • clinicians
  • patients
  • policy-makers
The written brief1 min read

What the work claims

CRISPR-Cas9 is a programmable genome editing tool. Cas9, directed by guide RNA, can be instructed to cut any DNA sequence. This transforms a bacterial immune mechanism into a universal molecular scalpel.

How it was done

Doudna and Charpentier combined Cas9 protein with synthetic guide RNA — a chimera of crRNA and tracrRNA — to direct DNA cleavage. They began collaborating in 2011 after meeting in San Juan, Puerto Rico. They demonstrated programmable cleavage by swapping guide RNAs to cut different DNA sequences.

What holds up

Cas9 cuts DNA when guided by RNA. The cut is programmable: changing the RNA sequence changes the DNA target. tracrRNA is essential for crRNA maturation. Synthetic guide RNA — combining crRNA and tracrRNA — enables cleavage at any desired DNA site in vitro.

What does not

The work did not demonstrate editing in human cells, embryos, plants or animals. It did not show repair outcomes, off-target effects, delivery methods, or therapeutic application. It did not establish safety, efficiency, or heritability.

Why it matters beyond the lab

It enabled precise, accessible, and scalable genome editing across biology and medicine. Its simplicity — one enzyme, one synthetic RNA — lowered the barrier to entry more than any prior editing technology. It shifted control of genetic manipulation from specialist labs to thousands of researchers worldwide.

Is it worth your time

Yes. It established the first programmable, RNA-guided DNA-cutting system using a single enzyme and synthetic RNA. This is the foundational protocol for CRISPR genome editing — not an incremental improvement, but the conceptual and practical origin point.

Same field · Genetics4 of 60
9:37
Induced pluripotent stem cellYamanakaiPSCs are somatic cells reprogrammed to pluripotency using four transcription factors. Demonstrated in 2006 in mouse fibroblasts via retroviral delivery and Fbx15 selection. Established direct reprogramming as possible—but only to the level of Fbx15 reactivation, not full pluripotency validation.
13:00
Meselson–Stahl experimentIn 1958, Matthew Meselson and Franklin Stahl tracked nitrogen isotopes through dividing E. coli DNA to decide which of three proposed replication mechanisms was correct. The banding pattern produced by density-gradient centrifugation matched only the semiconservative model already proposed by Watson and Crick, eliminating the conservative and dispersive alternatives and settling how the double helix passes on genetic information.
11:05
Central dogma of molecular biologyFrancis CrickCrick’s central dogma is a precise, unidirectional constraint on sequential information transfer — not a summary of known pathways. It was proposed theoretically, refined formally in 1970, and immediately misrepresented. Its endurance lies not in experimental confirmation but in its utility as a boundary condition: what molecular biology *cannot* do.
9:36
Stanley Norman Cohen1935Cohen and Boyer’s 1973 work established the first functional, replicable, cross-species gene transplantation system using defined molecular tools. It did not demonstrate control over expression levels, fidelity, or safety — only that bacterial cells could inherit and express foreign genes. Its power lies in reproducibility, not scope.
Up next in Science

3D printing

Chuck Hull · 9:54

3D printing isn’t manufacturing revolution—it’s geometry liberation.

Play nextBack to Genetics
9:54